The Establishment of Quantitatively Regulating Expression Cassette with sgRNA Targeting BIRC5 to Elucidate the Synergistic Pathway of Survivin with P-Glycoprotein in Cancer Multi-Drug Resistance
Open Access
- 3 January 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9, 797005
Abstract
Quantitative analysis and regulating gene expression in cancer cells is an innovative method to study key genes in tumors, which conduces to analyze the biological function of the specific gene. In this study, we found the expression levels of Survivin protein (BIRC5) and P-glycoprotein (MDR1) in MCF-7/doxorubicin (DOX) cells (drug-resistant cells) were significantly higher than MCF-7 cells (wild-type cells). In order to explore the specific functions of BIRC5 gene in multi-drug resistance (MDR), a CRISPR/Cas9-mediated knocking-in tetracycline (Tet)-off regulatory system cell line was established, which enabled us to regulate the expression levels of Survivin quantitatively (clone 8 named MCF-7/Survivin was selected for further studies). Subsequently, the determination results of doxycycline-induced DOX efflux in MCF-7/Survivin cells implied that Survivin expression level was opposite to DOX accumulation in the cells. For example, when Survivin expression was down-regulated, DOX accumulation inside the MCF-7/Survivin cells was up-regulated, inducing strong apoptosis of cells (reversal index 118.07) by weakening the release of intracellular drug from MCF-7/Survivin cells. Also, down-regulation of Survivin resulted in reduced phosphorylation of PI3K, Akt, and mTOR in MCF-7/Survivin cells and significantly decreased P-gp expression. Previous studies had shown that PI3K/Akt/mTOR could regulate P-gp expression. Therefore, we speculated that Survivin might affect the expression of P-gp through PI3K/Akt/mTOR pathway. In summary, this quantitative method is not only valuable for studying the gene itself, but also can better analyze the biological phenomena related to it.Keywords
Funding Information
- National Key Research and Development Program of China
- Youth Science Fund Project
This publication has 66 references indexed in Scilit:
- Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivinMolecular Cancer, 2014
- Multidrug-resistant breast cancer: current perspectivesBreast Cancer: Targets and Therapy, 2014
- Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cellsThe International Journal of Biochemistry & Cell Biology, 2013
- P-glycoprotein and survivin simultaneously regulate vincristine-induced apoptosis in chronic myeloid leukemia cellsInternational Journal of Oncology, 2011
- Survivin and P-glycoprotein are associated and highly expressed in late phase chronic myeloid leukemiaOncology Reports, 2011
- Survivin Enhances Motility of Melanoma Cells by Supporting Akt Activation and α5 Integrin UpregulationCancer Research, 2010
- Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cellsOncology Reports, 2010
- Expressions and significance of Survivin, MDR1 and MRP in non-small cell lung cancer (NSCLC)The Chinese-German Journal of Clinical Oncology, 2008
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- The tet‐off system is more effective than the tet‐on system for regulating transgene expression in a single adenovirus vectorThe Journal of Gene Medicine, 2002